Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Myocarditis".)
●(See "Society guideline links: Interstitial lung disease".)
●(See "Society guideline links: Arrhythmias in adults".)
●(See "Society guideline links: Cardiomyopathy".)
International
●World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG): Statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension (2022)
●International Workshop on Ocular Sarcoidosis (IWOS): Revised criteria for the diagnosis of ocular sarcoidosis (2019)
●Heart Rhythm Society (HRS), American College of Cardiology (ACC), American College of Chest Physicians (ACCP), American Heart Association (AHA), Asia Pacific Heart Rhythm Society (APHRS), European Heart Rhythm Association (EHRA), and WASOG: Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis (2014)
United States
●Heart Failure Association (HFA), Heart Failure Society of America (HFSA), and Japanese Heart Failure Society (JHFS): Position statement on endomyocardial biopsy (2021)
●American Thoracic Society (ATS): Official clinical practice guideline for the diagnosis and detection of sarcoidosis (2020)
●Heart Rhythm Society (HRS): Expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (2019)
●European Association of Nuclear Medicine (EANM), European Association of Cardiovascular Imaging (EACVI), and American Society of Nuclear Cardiology (ASNC): Joint procedural position statement on imaging in cardiac sarcoidosis (2017)
●Society of Nuclear Medicine and Molecular Imaging (SNMMI)–ASNC: Joint expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring (2017)
●HRS, American College of Cardiology (ACC), American College of Chest Physicians (ACCP), American Heart Association (AHA), Asia Pacific Heart Rhythm Society (APHRS), European Heart Rhythm Association (EHRA), and World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG): Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis (2014)
Europe
●European Respiratory Society (ERS): Clinical practice guidelines on treatment of sarcoidosis (2021)
●European Association of Nuclear Medicine (EANM), European Association of Cardiovascular Imaging (EACVI), and American Society of Nuclear Cardiology (ASNC): Joint procedural position statement on imaging in cardiac sarcoidosis (2017)
United Kingdom
●British Thoracic Society (BTS): Clinical statement on pulmonary sarcoidosis (2020)
Australia–New Zealand
●Choosing Wisely Australia: Do not perform a serum ACE for the diagnosis or monitoring of sarcoidosis (reviewed 2021)
Japan
●[In English] Heart Failure Association (HFA), Heart Failure Society of America (HFSA), and Japanese Heart Failure Society (JHFS): Position statement on endomyocardial biopsy (2021)
●[In English] Japanese Circulation Society (JCS): Guideline on diagnosis and treatment of cardiac sarcoidosis, 2016 (published 2019)
●[In English] Japanese Society of Nuclear Cardiology (JSNC): Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis, 2018 update (published 2019)
●[In Japanese] JSNC: Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis, 2018 update (published 2019)
●[In Japanese] JCS: Guidelines for diagnosis and treatment of cardiac sarcoidosis (2016)